Sophia Humphreys | Vice President, Health System Strategy and Innovation
MJH Life Science | United States

Sophia Humphreys is an innovative, and dedicated Pharmacy executive with 20 plus years of pharmacy leadership experience. She is a nationally renowned leader for Medication Utilization Management, P&L and Pharmacy Operations. She uses her exceptional financial analysis skills and incorporates HEOR principles into strategic planning, clinical innovation, and operational standardization. She is a frequent keynote speaker and chair for national conferences and excels at building strategic connections between high-level health system executives and pharmaceutical industry leaders to foster innovation, collaboration, and high impact growth. She is a nationally known speaker and advisor for multiple pharmaceutical companies. Throughout her career, she has demonstrated excellence in communicating and forming partnerships with physician leaders, and other professional teams. Highlights regarding her achievements:

• Developed and implemented data-driven, evidence-based, and innovative UM programs, which yield >$10 million in drug savings annually for her employers.
• An unparalleled track record of overseeing large-scale drug budgets (exceeding $1B in each of the two most recent positions) in a manner that saves millions of dollars for the company while maintaining the highest standards in patient clinical outcomes.
• Expanded previously unpenetrated market for mail-order, specialty and retail pharmacy services, which yield >20% Prescription volume increase.

As a goal-driven professional, Sophia’s focus is on evaluating complex business landscapes, analyzing challenges, and developing effective solutions to reduce risk, improve operational efficiency, and positively impact financial sustainability. Leadership Experience -MJH Life Science -Credena Health w/ Providence -Sutter Health -Providence Health   -Omnicare of Seattle Profesional Socienty experience Executive Council Member, AJMC Advisory Board Member, World Biosimilar Congress Steering Committee member, Board Certified Biologics and Biosimilar Specialist by ACMA, Accreditation Council for Medical Affairs (ACMA) Editorial Ad. Board member: Pharmacy Times Oncology Edition EDUCATION & CERTIFICATE MHA, University of Cincinnati PharmD, University of Washington BCBBS, Accreditation Council of Medical Affairs ASHP Certified Pharmacogenomics Specialist